<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 09 Apr 2026 05:58:50 -0400--><rss version="2.0">
    <channel>
        <title>Intensity Therapeutics, Inc. (INTS) SEC Filings</title>
        <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/rss</link>
        <description>Intensity Therapeutics, Inc. (INTS) - All SEC Filings</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/intensitytherapeutics/files/theme/images/logo-sm.png</url>
                <title>Intensity Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001238705-26-000005/0001238705-26-000005.pdf</link>
                <pubDate>Mon, 30 Mar 26 17:30:19 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001238705-26-000005/0001238705-26-000005.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000025/0001567264-26-000025.pdf</link>
                <pubDate>Fri, 27 Mar 26 16:20:39 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000025/0001567264-26-000025.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]></title>
                <description><![CDATA[8 Related Documents: 10-K, EX-4.1, EX-19.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000024/0001567264-26-000024.pdf</link>
                <pubDate>Fri, 27 Mar 26 16:02:49 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000024/0001567264-26-000024.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-5.1]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000021/0001567264-26-000021.pdf</link>
                <pubDate>Mon, 23 Mar 26 16:02:30 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000021/0001567264-26-000021.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[424B5 - Prospectus [Rule 424(b)(5)]]]></title>
                <description><![CDATA[424B5]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000020/0001567264-26-000020.pdf</link>
                <pubDate>Mon, 23 Mar 26 16:01:08 -0400</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000020/0001567264-26-000020.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000014/0001567264-26-000014.pdf</link>
                <pubDate>Fri, 06 Mar 26 08:05:05 -0500</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000014/0001567264-26-000014.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[2 Related Documents: 8-K, EX-99.1]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000011/0001567264-26-000011.pdf</link>
                <pubDate>Thu, 05 Mar 26 08:07:58 -0500</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000011/0001567264-26-000011.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[8-K - Current report]]></title>
                <description><![CDATA[3 Related Documents: 8-K, EX-3.1, EX-99.1]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000007/0001567264-26-000007.pdf</link>
                <pubDate>Fri, 13 Feb 26 16:01:24 -0500</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000007/0001567264-26-000007.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[S-8 - Securities to be offered to employees in employee benefit plans]]></title>
                <description><![CDATA[4 Related Documents: S-8, EX-FILING FEES, EX-5, EX-23]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000003/0001567264-26-000003.pdf</link>
                <pubDate>Fri, 23 Jan 26 16:18:40 -0500</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001567264-26-000003/0001567264-26-000003.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[4 - Statement of changes in beneficial ownership of securities]]></title>
                <description><![CDATA[4]]></description>
                <link>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001895944-26-000003/0001895944-26-000003.pdf</link>
                <pubDate>Mon, 05 Jan 26 16:04:17 -0500</pubDate>
                <guid>https://ir.intensitytherapeutics.com/sec-filings/all-sec-filings/content/0001895944-26-000003/0001895944-26-000003.pdf</guid>
                                                                            </item>
            </channel>
</rss>